Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 8105536 | HLA-DPB1 (HLA-DPB1) | beryllium disease | NA | NA | NA | unclassified | |
| hla-dpb1 glutamate 69: a genetic marker of beryllium disease. | |||||||
| 8105536 | MHC (MHC) | beryllium disease | NA | NA | NA | unclassified | |
| chronic beryllium disease (cbd) is a lung disorder related to beryllium exposure and is characterized by the accumulation in the lung of beryllium-specific cd4+ major histocompatibility complex (mhc) class ii-restricted t lymphocytes. | |||||||
| 10415070 | HLA-DPB1 (HLA-DPB1) | beryllium disease | NA | NA | NA | unclassified | |
| differential susceptibilities to chronic beryllium disease contributed by different glu69 hla-dpb1 and -dpa1 alleles. | |||||||
| 10415070 | HLA-DPB1 (HLA-DPB1) | beryllium disease | NA | NA | NA | unclassified | |
| chronic beryllium disease (cbd) is associated with the allelic substitution of a glu69 in the hla-dpb1 gene. | |||||||
| 10860658 | HLA (HLA) | beryllium disease | NA | NA | NA | unclassified | |
| we have tested the new method by genotyping the glu69 variant from the hla dpb1 locus, a snp associated with chronic beryllium disease, as well as hla dpa1 alleles using the multiplexed method. | |||||||
| 11050177 | NA (NA) | beryllium disease | NA | NA | NA | unclassified | |
| beryllium presentation to cd4+ t cells underlies disease-susceptibility hla-dp alleles in chronic beryllium disease. | |||||||
| 11207315 | NA (NA) | beryllium disease | NA | NA | NA | unclassified | |
| hla-dp allele-specific t cell responses to beryllium account for dp-associated susceptibility to chronic beryllium disease. | |||||||
| 12173370 | HLA (HLA) | beryllium disease | African American | NA | NA | unclassified | |
| racial differences in prevalence of a supratypic hla-genetic marker immaterial to pre-employment testing for susceptibility to chronic beryllium disease. | |||||||
| 12620668 | NA (NA) | beryllium disease | NA | NA | NA | unclassified | |
| in an effort to understand the molecular basis of chronic beryllium disease (cbd), a study of the chemical relationship between beryllium, antigen, and the major histocompatibility complex ii, hla-dp, was undertaken. | |||||||
| 14630515 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | beryllium disease | NA | NA | NA | unclassified | |
| electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease. | |||||||
Copyright 2024